[Prolonged treatment with noxiptilin in depressions].
D000275:Adjustment Disorders / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy*; D003986:Dibenzocycloheptenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D001523:Mental Disorders / Q000188:drug therapy; D008728:Methotrimeprazine / Q000627:therapeutic use*; D008875:Middle Aged; D010259:Paranoid Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013997:Time Factors
D000927:Anticonvulsants; D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes; D008728:Methotrimeprazine
Langzeitbehandlung mit Noxiptilin bei Depressionen.